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Abstract: Background: Oral hygiene instructions (OHI) and periodontal nonsurgical treatment (PNST)
play pivotal roles in the management of periodontitis. The study aims to discern their respective
effects on periodontal clinical parameters and patient-reported outcome measures (PROMs). Methods:
Ninety-one patients were included, 34 non-smokers (NS), 25 former smokers (FS) and 32 current
smoker (CS). Clinical parameters such as probing depth (PD) and bleeding on probing (BOP) were
collected, and the periodontal inflamed tissue area (PISA) was calculated. Clinical parameters and
PROMs were recorded before and after receiving OHI, with electronic tooth brush and interdental
brushes, as well as 3 months after debridement. Results: Smokers presented a significantly higher
proportion of severe periodontitis (64.7%) with generalized extension (76.5%) and with a rapid rate
of progression (97.1%) compared to NS and FS. OHI led to a significant decrease of PD, BOP, and
PISA (p < 0.0001) only in NS and FS. Debridement reduced PD and the percentage of PD >6 mm
in all groups (p < 0.0001). OHI induced significant improvement of oral hygiene, frequency of
interdental cleaning, and PROMs (p < 0.0001). Further debridement induced significant additional
improvement PROMs in FS and NS (p < 0.0001). Conclusion: OHI and debridement improved
periodontal clinical parameters and PROMs in both NS and FS. Former smokers had comparable
outcomes to non-smokers, suggesting that smoking cessation should be encouraged.
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1. Introduction
According to the World Health Organization (WHO), oral health contributes to general health
and quality of life. Poor oral hygiene and its consequences on the individual such as periodontitis is
a recognized public health problem [1–3], as periodontal pathogens can reach the bloodstream and
contribute to the progression of systemic diseases [4–6]. Additionally, in the absence of treatment,
periodontal diseases can lead to tooth mobility, tooth loss, and halitosis that negatively affect patient
lifestyle with social, physical, and psychological repercussions [7–9]. Tobacco use and poor oral
hygiene combined an increase the risk of periodontitis not only by initiating but also by fostering
disease progression and affecting response to treatment [10,11].
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Smoking influences the host inflammatory and immune response and consequently participates in
the progression of periodontitis. In a recent systematic review [12], the authors concluded that smoking
increases the risk of periodontitis by 85% (risk ratio 1.85, 95% confidence interval: 1.5–2.2). Indeed,
the addiction impairs periodontal wound healing, as reviewed by Labriola et al. [13], contributing
to disease progression. The effect of initial periodontal therapy in smoking versus non-smoking
patients was widely explored in the literature. A better reduction in probing depths, clinical attachment
level, bleeding on probing, and plaque index was consistently found in non-smokers compared to
smokers [14–21].
Inadequate self-performed plaque control is also recognized as a risk factor of periodontitis [1,22,23],
causing the inflammatory destruction of the connective tissue supporting tooth, with gingival bleeding
and halitosis, which are considered poor patient-related outcomes [24,25]. In the same context, a recent
European Workshop of Periodontology highlighted the role of practitioners in providing oral hygiene
instructions and home care in the prevention of periodontal disease [23,26,27].
Beside the systemic management of periodontitis as well as patient information, the initial
treatment involves both oral hygiene instructions (OHI) and periodontal nonsurgical treatment (PNST)
by a professional mechanical plaque removal including supra and subgingival debridement [2].
However, to the best of our knowledge, the respective effects of these two treatment aspects have
never been investigated in the literature. Indeed, most data available concerning the effect of the
initial periodontal therapy evaluate the impact of oral hygiene instructions and debridement together.
However, discerning the individual impact on oral health of OHI and debridement on clinical
parameters and patient-reported outcome measures (PROMs) would help emphasize the respective
and synergic roles of the patient and the periodontist.
This controlled prospective study aimed to explore the respective effects of oral hygiene
instructions and periodontal debridement on clinical parameters and patient-related outcomes in
relation to smoking.
2. Material and Methods
2.1. Study Design
The present study was designed as a single-center, prospective, controlled study focusing on the
effect of oral hygiene instructions and PNST on clinical features and PROMs with respect to smoking.
The study followed and respected the items of the “STrengthening the Reporting of OBservational
studies in Epidemiology (STROBE)” statement for cohort study.
The study was approved on 12 February 2014 by the ethical committee of the University Hospital of
Liege, Belgium (B707201421977) and was registered on clinicaltrial.gov (NCT04061460). The goals of the
study were carefully explained, and all patients signed an informed consent form (Figure 1: Flowchart).
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Figure 1. Flowchart: study design. 
2.2. Study Population 
Patients presenting with chronic periodontitis and requiring periodontal treatment were 
recruited in the Department of Periodontology and Oral Surgery at the University Hospital of Liège, 
Belgium (CHU, Sart-Tilman) according to the following inclusion criteria: (1) aged at least 18 years 
old, (2) chronic periodontitis, (3) presence of a minimum of 6 teeth at each arch, (4) a minimum of 6 
teeth with pocket depth of 5 mm, and (5) signed informed consent. The exclusion criteria were as 
follows: (1) aggressive periodontitis, (2) diabetes, (3) connective tissue disease, (4) pregnancy, (5) 
radiotherapy, (6) chemotherapy, (7) psychological disease, and (8) previous periodontal therapy. 
Prospective participants were screened for enrolment in the study according to the inclusion and 
exclusion criteria. Participants who complied with the inclusion criteria were enrolled in the study 
according to their smoking status: non-smoker (NS), former smoker (FS), or current smoker (CS). 
They were provided with written information concerning the study requirements. 
2.3. Clinical Procedure 
2.3.1. Oral Hygiene Instructions 
After a full initial periodontal examination, all patients received information about the genesis 
and the overall treatment of periodontitis. Additionally, detailed oral hygiene instructions were 
provided including teeth brushing, interdental cleaning, and tongue wash according to the gold 
standard strategies [3,28–30]. At the end of the first visit, they received a prescription for an electronic 
toothbrush and individual interdental brushes.  
2.3.2. Professional Mechanical Plaque Removal 
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2.2. Study Population
Patients presenting with chronic periodontitis and requiring periodontal treatment were recruited
in the Department of Periodontology and Oral Surgery at the University Hospital of Liège, Belgium
(CHU, Sart-Tilman) according to the following inclusion criteria: (1) aged at least 18 years old, (2)
chronic periodontitis, (3) presence of a minimum of 6 teeth at each arch, (4) a minimum of 6 teeth with
pocket depth of 5 mm, and (5) signed informed consent. The exclusion criteria were as follows: (1)
aggressive periodontitis, (2) diabetes, (3) connective tissue disease, (4) pregnancy, (5) radiotherapy, (6)
chemotherapy, (7) psychological disease, and (8) previous periodontal therapy. Prospective participants
were screened for enrolment in the study according to the inclusion and exclusion criteria. Participants
who complied with the inclusion criteria were enrolled in the study according to their smoking status:
non-smoker (NS), former smoker (FS), or current smoker (CS). They were provided with written
information concerning the study requirements.
2.3. Clinical Procedure
2.3.1. Oral Hygiene Instructions
After a full initial periodontal examination, all patients received information about the genesis
and the overall treatment of periodontitis. Additionally, detailed oral hygiene instructions were
provided including teeth brushing, interdental cleaning, and tongue wash according to the gold
standard strategies [3,28–30]. At the end of the first visit, they received a prescription for an lectronic
toothbrush and individual interdental brushes.
2.3.2. Professional Mechanical Plaque Removal
All the patients underwent a professional mechanical plaque removal, involving a supragingival
debridement 2 weeks after the first visit and a full mouth subgingival debridement 2 weeks later
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using ultrasonic piezoelectric device with specific micro-inserts (Newtron P5 XS Bled, Acteon, Satelec,
France). Debridement was performed by a single periodontist (L.S).
2.3.3. Smoking Status
The smoking status was recorded in two ways: (1) the number of cigarettes consumed per day
(NCC), and (2) the Fagerström test for nicotine dependence (FTND) [31].
2.3.4. Periodontal Evaluation
Patients were subjected to a comprehensive periodontal examination including the collection
of all periodontal clinical parameters and PROMs at baseline, 2 weeks after OHI, before and after
supragingival debridement, and 3 months after the subgingival debridement (Figure 1).
2.4. Data Collection
2.4.1. Periodontal Clinical Measurements
The periodontal examination was conducted by a single periodontist (L.S) and included the
following: probing depth (PD), gingival recession (RD), clinical attachment level (CAL), bleeding on
probing (BOP), plaque score index (PI), furcation, tooth mobility, percentage of sites of PD ≥6 mm, and
the number of missing teeth. A graduated manual periodontal probe (North Carolina 2927.10, Stoma,
Germany) was used to take measurements at the 6 sites of each tooth. BOP (%) and plaque score (%)
were collected according to Silness and Loe [32]. Tooth mobility was assessed according to the Miller
classification with a score ranging from 1 to 3 [33]. The furcation impairments were diagnosed with a
Nabers probe according to the classification of Hamp [34], and the periodontal inflamed surface area
(PISA) was calculated [35]. Patients were classified according to the new periodontal classification [36]
identifying the grade, the stage, and the extent of the periodontitis.
2.4.2. Patient-Reported Outcome Measures (PROMs)
A questionnaire using a visual analog scale (VAS) was given to all participants regarding their
oral hygiene habits and their perception of oral esthetic. It included the following questions scored
from 0 to 10: (1) “How do you judge your degree of oral hygiene?” (0: very bad, 10: excellent), (2)
“What is the frequency of utilization of interdental brushing?” (0: never, 5: twice per month, 7: once
per week, 8: twice per week, 9: third per week, 10: daily), (3) “Do you like the color of your teeth?”(0:
not at all, 10: yes, absolutely), (4) “Are your teeth sensitive to cold?”(0: not at all, 10: yes, extremely),
(5) “How do you judge your degree of gingival health?”(0: very bad, 10: excellent), (6) “How do you
judge the esthetic aspect of your gums?” (0: very low, 10: excellent), (7) “Do you like the color of your
gums?” (0: not at all, 10: yes, extremely), (8) “Do your gums bleed during brushing?” (0: not at all, 10:
yes, every day), and (9) “How do you judge your breath?” (0: very low, 10: excellent).
All the periodontal clinical parameters, the patient oral hygiene habits, and the patient-centered
outcomes were recorded in an online remote controlled and secured database.
2.5. Statistical Analyses
The primary outcomes and the null hypothesis of the study were respectively, probing depth
(PD) and “no change in the primary endpoint after treatment”. Results were presented as mean and
standard deviation (SD) for continuous parameters and as frequency tables for categorical variables.
On graphs, mean values were reported with their standard error (SE). Time-related data were analyzed
by linear mixed models with time, group, and time × group interactions as fixed factors and patients
as random elements. Regression coefficients were given with their standard error (SE). All p-values
were adjusted by Scheffé’s method for multiple comparisons. Results were considered significant at
the 5% critical level (p < 0.05). All calculations and graphs were performed with SAS version 9.4 for
Windows and R version 3.6.1.
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3. Results
3.1. Patient Characteristics
A total of 91 patients were included in the study (Table 1). Their mean age was 47.3 ± 12.2
years, of which 59.3% were men and 40.7% were women. According to smoking status, patients were
distributed as follows: non-smokers (n = 32), former smokers (n = 25), and smokers (n = 34). The three
groups did not differ with respect to age and gender. However, smokers presented more frequently
with severe (stage IV) periodontitis, potential for dentition loss (62.9%), generalized extension (52.0%),
and with a rapid rate of progression (97.1%) compared to the non-smokers and former smokers.
Table 1. Patient demographic characteristics, periodontitis classification, and smoking status
Variable Category
Total Current Smoker Former Smoker Non-Smoker p-Value
n = 91 n = 34 n = 25 n = 32
Demography
Age (mean ± SD, years) 47.3 ± 12.2 46.5 ± 11.5 51.2 ± 11.6 45.0 ± 12.9 0.14
Gender (n, %) 0.84
Female 54 (59.3) 20 (58.8) 16 (64.0) 18 (56.3)
Man 37 (40.7) 14 (41.2) 9 (36.0) 14 (43.8)
Dental characteristics
Missing teeth (n, %) 446 (15.4) 230 (21.3) 112 (14.1) 104 (10.3) <0.0001
Periodontitis classification
Stage (n; %)
III 60 (65.9) 15 (44.1) 19 (76.0) 26 (81.3) 0.0029
IV 31 (34.1) 19 (55.9) 6 (24.0) 6 (18.7)
Extent (n, %)
L 42 (46.2) 9 (26.5) 14 (56.0) 19 (59.4) 0.011
G 48 (52.8) 25 (73.5) 11 (44.0) 12 (37.5)
M-I 1 (1.1) 0 (0.0) 0 (0.0) 1 (3.1)
Grade (n, %)
A 44 (48.3) 0 (0.0) 18 (72.0) 26 (81.2) <0.0001
B 15 (16.5) 2 (5.9) 7 (28.0) 6 (18.8)
C 32 (35.2) 32 (94.1) 0 (0.0) 0 (0.0)
At baseline (Table 2), smokers also presented with significantly higher PD (p = 0.0019), mean and
max CAL (p < 0.0001), and percentage of PD > 6 mm (p = 0.036) compared to the others, and it remained
generally so throughout the treatment phases. By contrast, they had lower PISA scores (p < 0.001) and
BOP% (p < 0.0001), but their plaque index was comparable (p = 0.20). Periodontitis classification and
periodontal clinical parameters were comparable between former smokers and non-smoker patients.
PROMs recorded at baseline (Table 3) showed that current smokers had lower interdental scores (p =
0.028), esthetic assessment of their gums (p < 0.0001) and color of their gums (p = 0.0087); otherwise,
they were comparable to former smokers and non-smokers. During follow-up, despite oversampling
(n = 91 instead of n = 75), several patients were lost or withdrew from the study, leaving 88 patients
(respectively 31, 25, and 32 for current smokers, former smokers, and non-smokers) after OHI (2 weeks)
and 50 patients (respectively, 14, 19, and 17) after PNST (3 months). When comparing the baseline
(demographic, periodontal, and esthetic) data of completers and lost-to-follow patients in each group,
no significant differences were found in their characteristics.
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Table 2. Effect of oral hygiene instructions and debridement on periodontal clinical parameters
Characteristic Baseline After Oral Hygiene Instructions (b) After Debridement (c)
Population
Current smoker 34 31 14
Former smoker 25 25 19
Non-smoker 32 32 17
Variable (a) (mean ± SD)
PISA (mm2)
CS 265 ± 470 139 ± 404 4.22 ± 15.8
FS 1176 ± 635 195 ± 207 * 22.8 ± 88.7
NS 1170 ± 632 366 ± 364 * 40.9 ± 94.3
(p < 0.001) (d) (p = 0.028) (p = 0.44)
Mean PD (mm)
CS 3.78 ± 1.05 3.74± 1.01 2.30 ± 0.53 *
FS 3.27 ± 0.70 3.14 ± 0.72 1.84 ± 0.28 *
NS 3.05 ± 0.63 2.93 ± 0.66 1.86 ± 0.33 *
(p = 0.0019) (p = 0.0006) (p = 0.0021)
Max PD (mm)
CS 8.00 ± 1.21 7.97 ± 1.22 6.29 ± 1.90 *
FS 7.80 ± 1.19 7.76 ± 1.16 4.68 ± 1.16 *
NS 7.72 ± 1.11 7.72 ± 1.11 4.76 ± 0.97 *
(p = 0.61) (p = 0.67) (p = 0.0027)
Variable * (mean ± SD)
Mean CAL (mm)
CS 4.34 ± 1.40 4.17 ± 1.34 2.72 ± 0.67 *
FS 3.40 ± 0.81 3.26 ± 0.84 1.88 ± 0.30 *
NS 3.10 ± 0.68 2.97 ± 0.69 1.92 ± 0.38 *
(p < 0.0001) (p < 0.0001) (p < 0.0001)
Max CAL (mm)
CS 9.56 ± 2.48 9.26 ± 2.38 8.14 ± 2.71 *
FS 8.16 ± 1.52 8.12 ± 1.51 5.11 ± 1.20 *
NS 8.06 ± 1.46 7.91 ± 1.30 5.00 ± 1.22 *
(p = 0.0032) (p = 0.0091) (p < 0.0001)
Mean BOP (%)
CS 12.0 ± 23.0 6.24 ± 18.5 0.42 ± 1.58
FS 52.6 ± 26.1 5.66 ± 6.08 * 1.21 ± 4.69
NS 54.5 ± 27.3 11.7 ± 13.3 * 1.55 ± 3.22
(p < 0.0001) (p = 0.19) (p = 0.67)
Mean PI (%)
CS 86.4 ± 17.7 41.0 ± 28.2 * 30.4 ± 21.1
FS 80.9 ±17.8 6.11 ± 7.05 * 11.3 ± 15.3
NS 77.8 ± 22.9 13.1 ± 13.0 * 9.38 ± 10.1
(p = 0.20) (p < 0.0001) (p = 0.0009)
% PD > 6 mm
CS 19.0 ± 16.0 18.2 ± 15.5 2.92 ± 3.45 *
FS 12.9 ± 8.71 12.7 ± 8.54 0.25 ± 0.75 *
NS 11.9 ± 7.61 11.7 ± 7.30 0.42 ± 1.19 *
(p = 0.036) (p = 0.054) (p = 0.0007)
(a) CS = current smoker, FS = former smoker, NS = non-smoker, PISA = periodontal inflamed surface area, PD =
probing depth, CAL = clinical attachment level, BOP = bleeding on probing, PI = plaque index; percent, mean and
max values derived from 6 sites measurements for each tooth. (b) * the asterisk indicates a significant change from
baseline after oral hygiene instructions (all p-values derived by linear mixed models were less than 0.0001 adjusted
for multiple comparisons). (c) * the asterisk indicates a significant change from after debridement compared to after
oral hygiene instructions (all p-values derived by linear mixed models were less than 0.0001 adjusted for multiple
comparisons). (d) The p-values in parentheses assess the comparison of groups and at time point (baseline, after oral
hygiene instructions, and after debridement).
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Table 3. Effect of oral hygiene instructions and debridement on patient-reported outcome measures
(PROMs)





Degree of oral hygiene
CS 5.1 ± 2.1 7.1 ± 2.2 * 7.7 ± 2.5
FS 5.6 ± 1.6 8.3 ± 1.5 * 9.6 ± 0.70
NS 5.5 ± 1.8 8.7 ± 1.2 * 9.5 ± 0.80
(p = 0.51) (d) (p = 0.0013) (p = 0.0013)
Interdental hygiene
CS 1.6 ± 3.1 9.1 ± 1.4 * 8.3 ± 2.7
FS 3.9 ± 3.4 9.6 ± 1.5 * 9.2 ± 1.2
NS 3.3 ± 3.5 9.8 ± 0.4 * 9.5 ± 1.1
(p = 0.028) (p = 0.11) (p = 0.16)
Teeth color
CS 3.0 ± 2.2 3.2 ± 2.1 4.9 ± 2.7 *
FS 3.4 ± 1.7 3.7 ± 1.5 7.6 ± 0.92 *
NS 3.8 ± 2.1 4.7 ± 1.9 8.2 ± 0.83 *
(p = 0.31) (p = 0.0075) (p < 0.0001)
Sensitivity
CS 3.2 ± 2.6 3.6 ± 2.2 5.0 ± 2.3
FS 3.6 ± 1.6 3.8 ± 1.5 7.3 ± 1.0 *
NS 4.0 ± 1.9 4.6 ± 1.7 7.8 ± 1.2 *
(p = 0.29) (p = 0.076) (p < 0.0001)
Gingival health
CS 4.3 ± 2.5 4.2 ± 2.3 5.1 ± 1.8
FS 4.2 ± 1.7 4.2 ± 1.8 7.4 ± 1.0 *
NS 5.0 ± 1.6 5.2 ± 1.5 7.9 ± 1.0 *
(p = 0.20) (p = 0.058) (p < 0.0001)
Esthetic assessment of
the gums
CS 3.1 ± 3.0 2.0 ± 1.9 0.86 ± 1.3
FS 6.0 ± 3.1 1.2 ± 0.88 * 0.61 ± 1.9
NS 7.3 ± 2.5 1.0 ± 0.76 * 0.18 ± 0.73
(p < 0.0001) (p = 0.0086) (p = 0.39)
Color of the gums
CS 2.8 ± 2.2 3.0 ± 2.0 3.9 ± 2.5
FS 4.1 ± 2.1 4.4 ± 2.1 5.2 ± 2.2
NS 4.6 ± 2.5 5.0 ± 2.3 5.8 ± 2.0
(p = 0.0087) (p = 0.0011) (p = 0.068)
Bleeding on brushing
CS 4.6 ± 2.9 4.6 ± 3.0 3.5 ± 3.1
FS 5.2 ± 2.0 4.8 ± 2.3 0.89 ± 1.5 *
NS 3.7 ± 2.6 3.3 ± 2.6 0.41 ± 1.2 *
(p = 0.088) (p = 0.049) (p = 0.0002)
Good breath/Halitosis
CS 4.3 ± 2.0 4.6 ± 1.5 5.8 ± 1.8
FS 5.0 ± 1.9 6.2 ± 1.3 8.3 ± 1.0 *
NS 5.2 ± 2.2 6.0 ± 1.7 8.5 ± 0.80 *
(p = 0.19) (p = 0.0002) (p < 0.0001)
(a) CS = current smoker, FS = former smoker, NS = non-smoker; Questionnaire: “1/How do you judge your degree
of oral hygiene?” (0: very bad, 10: excellent), 2/ “What is the frequency of utilization of interdental brushing?” (0:
Never, 5: twice per month, 7: once per week, 8: twice per week, 9: three times per week, 10: daily), 3/ “Do you like
the color of your teeth?” (0: Not at all, 10: Yes, absolutely), 4/“Are your teeth sensitive to cold?”(0: Not at all, 10:
Yes, extremely), 5/ “How do you judge your degree of gingival health?”(0: very bad, 10: excellent), 6/ “How do
you judge the esthetic aspect of you gums?” (0: very low, 10: excellent), 7/ “Do you like the color of your gums?”
(0: Not at all, 10: Yes, extremely), 8/ “Do your gums bleed during brushing?” (0: Not at all, 10: Yes, every day), 9/
“How do you judge your breath?” (0: very low, 10: excellent). (b) * the asterisk indicates a significant change from
baseline after oral hygiene instructions (all p-values derived by linear mixed models were less than 0.0001 adjusted
for multiple comparisons). (c) * the asterisk indicates a significant change from after debridement compared to after
oral hygiene instructions (all p-values derived by linear mixed models were less than 0.0001 adjusted for multiple
comparisons). (d) The p-values in parentheses assess the comparison of groups and at each time point (baseline,
after oral hygiene instructions, and after debridement).
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3.2. Effects on Periodontal Clinical Parameters
As seen in Table 2 and Figure 2, oral hygiene instructions led to a highly significant decrease of
PISA and mean BOP (%) values (p < 0.0001) in former and non-smokers but in not in current smokers
(p = 0.94). OHI also significantly reduced the mean plaque index in all three groups (p < 0.0001)
with reductions of 74.8% in former smokers, 64.7% in non-smokers, and 45.4% in smokers. The other
periodontal parameters (mean and max PD, mean and max Cal, % PD > 6 mm) remained unchanged.
Full mouth subgingival debridement induced an additional significant reduction (p < 0.0001) in all
periodontal parameters in all three smoking groups except for PISA, Mean BOP (%), and mean plaque
index where values remained unchanged. Of important note, the mean PD dropped by 1.44 mm in
smokers, 1.30 mm in former smokers, and by 1.07 mm in non-smokers. Similarly, max PD decreased
by 1.68, 3.08, and 2.96 mm, respectively. The percentage of PD >6 mm went down from 18.2 to 2.92 in
current smokers, 12.7 to 0.25 in former smokers, and 11.7 to 0.42 in non-smokers.
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3.3. Effects on PROMs
The respective effects OHI and debridement on PROMs are described in Table 3 and Figure 3.
OHI positively and markedly influenced pati t reporting of their oral hygiene degree and of the
frequency of interdental cl aning in the 3 groups (all adjusted p-values < 0.0001). The sth tic aspect of
the gum was also significantly improved in former an non-smokers (p < .0001) but not in curr nt
smokers (p = 0.54). All the other items remained uncha ged in each group. According to pati t
reporting, debridement did not further improve PROMs i smokers, except for a borderline effect on
t eth color (p = 0.048). By co trast, debridement significantly enhanced te th c lor, sensitivity, gingival
health, bleeding on brushing, and goo reath/halitosis scores in former smokers and non-smokers
(all p < 0.0001).
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4. Discussion
To the best of our knowledge, the present study is the first to discern the separate effects of oral
hygiene instructions and debridement on periodontal clinical parameters and PROMs according to
smoki g sta us (non-smokers, for r smokers, and current smokers).
O the one hand, the oral hygiene instructions were responsible for a significant decrease (>50%)
of the mean plaque index in the thre groups of PISA and BOP (%) on y in non-smokers (NS) and former
smokers (FS). Indeed, higher reductions of plaque index were found in these tw groups compared to
the smoker group. In the case of gingivitis, it was widely demo strated that plaque control significantly
improves gingival inflammation a d BOP [3]. In add tion, a recent systematic review confirmed that
the mechanical plaque control procedures are effective in re ucing plaque n gingivitis [22]. Moreover,
in non-smokers and form r smokers, the oral hygiene improvement contribut d to the o tro of the PI,
which participates in the decrease of BOP and hence f the PISA [3]. As kn wn, the nteractions among
human oral bac eria, called the oral microbiome, are integral to the dev l pment and maturation of the
plaque [37]. Therefore, the NS and FS groups with high complianc t plaque control p sented a
hig r control of their oral microbiome than the CS group. H wever, the study highlighted a low
of smok rs with respect to instructions on den al hygiene. The bas line BOP and PISA
values of smokers were already low and were not influenced by the im rovemen of plaque control.
This observation ca be explained by the fact that smoking suppresses the inflammatory gingival
response to the plaque accumulation as well as the gingiv l bl eding (BOP) [38]. Furthermore, in a
tudy inves igating host response during experimental gingivitis, the authors did a so observe th t
smokers had less bleeding and a higher proportion of visible plaque ind x (VPI) than on-smokers [39].
Of note, OHI h d n influence whatsoever on PD and CAL.
On the other hand, the debride ent led to a significant reducti n of the mean PD (>1 mm),
which is the primary outcome measure of this study, and of the percentage of PD >6 mm (>10%) in
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all three groups (p < 0.0001), also with a higher reduction in non-smokers and former smokers. The
same observation was also made for the clinical attachment level. The reduction of PI, BOP, and PD
after initial periodontal therapy was widely demonstrated in clinical studies [15–21] and systematic
reviews [40,41]. However, the present study highlights the effectiveness of plaque control (PI) on both
the inflammation level (BOP) and probing depth reduction in non-smokers and former smokers, while
in smokers, periodontal debridement solely improves clinical periodontal parameters. These findings
also emphasized the benefits of smoking cessation on periodontal outcomes as recently described in a
WHO systematic review and meta-analysis on the effects of tobacco use cessation [42].
Clinical outcomes after both OHI and PNST in smokers were limited, which could be attributed
to the impact of smoking on inflammatory and immune host responses and also to the negative
vasoconstrictive effect of nicotine. This addiction decreases the phagocytes population [43,44], the
number and the chimiotactisms of neutrophils [45,46], and it interacts with the lymphocytes blood
circulation [47,48] with the consequence of low bacteria destruction. This could explain the lower
reduction of PI in smokers. Moreover, since the vasoconstrictive effect of tobacco smoke [49] leads to the
diminution of blood cells in the capillaries, no significant reduction of BOP could be observed in smokers,
neither after OHI nor after PNST. Additionally, nicotine induces the apoptosis of fibroblasts [50,51] that
also perturbs wound healing and the pocket depth reduction after debridment. It is relevant to note
that the present controlled prospective study highlighted the positive effect of smoking cessation to the
response of initial periodontal therapy. Our findings confirm those of a recent systematic review which
concluded that in former smokers, the risk for periodontitis becomes comparable to never-smokers
and that nonsurgical periodontal treatment improves clinical outcomes after smoking cessation [12].
Patient-centered outcome assessment is now being considered as a primary outcome measure
in clinical trials, as described in a recent systematic review [52]. In the extant literature on PROMS
after PNST, the authors mostly use a visual analog scale (VAS) and questionnaires to evaluate patient’s
quality of life [53,54], level of anxiety, and/or the pain [54–56]. However, there is a clear lack of
information concerning the patient’s esthetic perception of gums, bleeding [57], and color of gums and
teeth, which are related simultaneously to OHI. In the present study, all patients were compliant to
OHI, and most PROMs scores improved except for the patient’s perception of his/her “gum esthetic”,
which significantly decreased in former smokers and non-smokers. This could be explained by the fact
that at baseline, the initial questionnaire was filled in before any periodontal clinical measurements
or any information about periodontitis genesis and classification was available; therefore, at the
second visit, when patients became aware of their gum situation, they tended to express a worst
perception. The present study clearly evidenced that after debridement, outcome measures such
as teeth color, sensitivity, gingival health, bleeding on brushing, and good breath/halitosis were
considerably improved in the patient’s perception but only in former smokers and non-smokers.
Perception did not change in current smokers. Of note, the patient’s degree of interdental hygiene
tends to decline with time with even less compliance in smokers, so that it is essential to promote the
necessity of maintenance recall. Specifically, patients should be compliant in their oral health and in the
follow-up of their periodontal treatment, and practitioners should employ the motivational counseling
and microbiome control through supra debridement. Decades ago, some authors [58] stressed the
role of the maintenance care program to prevent the recurrence of periodontitis. Some years later,
the authors made a long-term study of 30 years and concluded that preventive dental treatment was
beneficial for maintaining a high standard of oral hygiene. Moreover, for the compliant patient, the
incidence of caries and periodontal disease as well as tooth mortality was quite low [59]. In a systematic
review of 19 studies evaluating the efficacy of long-term professional mechanical plaque removal [60],
the authors concluded that the periodontal maintenance called “supportive therapy” may limit the
incidence and yearly rate of tooth loss as well as the loss in clinical attachment in patients treated
for periodontitis. Additionally in a workshop on primary and secondary prevention of periodontal
and peri-implant diseases [2], the authors concluded that professional mechanical plaque removal as
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the sole element of professional preventive care is inappropriate without education and behavioral
changes to sustained improvements in health status.
The main limitation of the present study could be related to this proportion of drop-outs after
the periodontal subgingival debridement, despite a larger sample size (n = 91) than foreseen (n =
75) at enrollment to cope with the potential loss of subjects. This shortcoming may be attenuated by
the following arguments: (1) all patients (completers and drop-outs) received the entire treatment
sequence (OHI + PNST), (2) no significant differences were found between completers and drop-outs
at baseline, (3) the statistical analysis used linear mixed effects models which included all longitudinal
data available of complete and drop-outs subjects, (4) all p-values from the linear mixed models were
adjusted for multiple comparisons, and (5) despite drop-outs, the null hypothesis of no change in
the primary endpoint “probing depth (PD)” after treatment was rejected at a high significance level
(adjusted p-value < 0.0001) with a mean observed effect size >1 mm in each group.
5. Conclusions
Oral hygiene instructions and PNST combined play pivotal roles in the global periodontal
treatment. Separate improvements of periodontal clinical outcomes and PROMs due respectively to
OHI and PNST were observed in non-smokers and former smokers. In current smokers, improvements
were only visible after PNST. Periodontists should welcome and encourage smoking cessation by
supporting the idea that former smokers have comparable outcomes to non-smokers. Moreover, there
is a need to promote the impact of recall maintenance in the promotion of good oral health. Finally,
long-term multicentric studies will be needed to evaluate the contribution of OHI in the success of
periodontal non-surgical treatment and to assess quality of life.
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